Oestrogen deficiency modulates particle-induced osteolysis
© Nich et al.; licensee BioMed Central Ltd. 2011
Received: 4 January 2011
Accepted: 22 June 2011
Published: 22 June 2011
Postmenopausal osteoporosis may modulate bone response to wear debris. In this article, we evaluate the influence of oestrogen deficiency on experimental particle-induced osteolysis.
Polyethylene (PE) particles were implanted onto the calvaria of normal controls, sham-ovariectomized (OVX), OVX mice and OVX mice supplemented with oestrogen (OVX+E). After 14 days, seven skulls per group were analyzed using a high-resolution micro-computed tomography (micro-CT) and histomorphometry, and for tartrate-specific alkaline phosphatase. Five calvariae per group were cultured for the assay of IL-1β, IL-6, TNF-α and receptor activator of the nuclear factor κB (RANKL) secretion using quantitative ELISA. Serum IL-6 concentrations were obtained. The expression of RANKL and osteoprotegerin (OPG) mRNA were evaluated using real-time PCR.
As assessed by μCT and by histomorphometry, PE particles induced extensive bone resorption and an intense inflammatory reaction in normal controls, sham-OVX and OVX+E mice, but not in the OVX mice group. In normal controls, sham-OVX and OVX+E mice, PE particles induced an increase in serum IL-6, in TNF-α and RANKL local concentrations, and resulted in a significant increase in RANKL/OPG messenger RNA (mRNA) ratio. Conversely, these parameters remained unchanged in OVX mice after PE implantation.
Oestrogen privation in the osteolysis murine model ultimately attenuated osteolytic response to PE particles, suggesting a protective effect. This paradoxical phenomenon was associated with a down-regulation of pro-resorptive cytokines. It is hypothesized that excessive inflammatory response was controlled, illustrated by the absence of increase of serum IL-6 in OVX mice after PE implantation.
Aseptic loosening of total joint replacements develops as a consequence of periprosthetic osteolysis, caused by a macrophage-mediated inflammatory reaction [1, 2]. Although it is well established that generation of polyethylene (PE) particles by the bearing couple is correlated with the risk for revision due to aseptic loosening , great variations in the degree of osteolysis are sometimes observed in clinical practice. This suggests that patient-related factors cause variability in the host response to PE particles. Authors have reported various factors, such as genetically determined obesity , and genetic background , as potential candidates involved in the modulation of host response to PE particles. In a recent work, we evaluated the bone response to particulate debris in an ovariectomized mice model . We hypothesized that high bone turnover driven by oestrogen deficiency following ovariectomy would result in accelerated bone loss in the area in contact with the PE particles. Paradoxically, particle-induced osteolysis was found significantly decreased in this model, indicating that ovariectomy could be protective against wear debris-induced osteolysis, possibly via sex steroid hormone deficiency. Particle-induced osteolysis has been shown to follow a biologic pathway, driven by cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α. These mediators have been found in the soft tissue of joints with loosened prostheses  and appear to be released by human macrophage or macrophagelike cells in vitro . There is evidence that the RANK (receptor activator of the nuclear factor κB)/RANKL (RANK ligand) system acts downstream from IL-1, IL-6 and TNF-α and may be the ultimate effector mediating the effects of cytokines on the regulation of bone resorption . Ovariectomy has been shown to decrease bone mass, stimulate bone remodeling, and increase IL-6 levels in bone marrow [10, 11], and to produce an osteoporotic bone phenotype, similar to postmenopausal osteoporosis. Interestingly, high levels of the three above-mentioned cytokins have been found in bone deprived of oestrogen .
Although the osteoprotective action of oestrogen is demonstrable in rodents, its implication in particle-induced osteolysis has never been shown. The purpose of the present study was to investigate the influence of oestrogen on the mechanism underlying particle-induced osteolysis in the murine calvaria model. Following our previous findings, we primarily hypothesized that oestrogen supplementation in ovariectomized mice would restore an extensive bone response to PE particles. In an attempt to shed light on possible underlying regulation, we secondly evaluated the local implication of the RANK/RANKL/OPG system and IL-1β, IL-6, TNF-α cytokins.
Materials and methods
Pure polyethylene particles (Ceridust VP 3620) were obtained from Clariant (Gersthofen, Germany). In our hands, the particle size was determined using scanning electron microscopy as previously detailed . The mean particle size was 5.14 μm ± 3.05 μm (median 4.39 μm; range 0.52 to 15.5 μm). More than 55% of the particles were less than 5 μm in size. All particles were washed in ethanol to remove endotoxins, and then dried in a dessicator . This treatment resulted in negative testing for endotoxins using a quantitative Limulus Amebocyte Lysate (LAL) Assay (Charles River, Margate, UK) at a detection level of <0.05 EU/mL. Particles were stored at 4°C before implantation.
Animal surgery and experimental protocol
Eleven week-old C57BL/6J female mice (n = 96) were purchased from Janvier Laboratory (Le Genest-Saint-Isle, France). All mice were handled in agreement with French and international guidelines for care and use of laboratory animals. The protocol was given ethical approval by the local Animal Care Committee. Forty-eight mice were subjected to bilateral ovariectomy (OVX group) via the dorsal approach under general anesthesia (isoflurane). Twenty-four mice were sham-ovariectomized (sham-OVX), that is, ovaries were exteriorized, but not removed. Twenty-four non-OVX mice constituted the normal control group. Animals were housed in quarantine under local vivarium conditions (24°C and 12 h/12 h light/dark cycle) for one week.
Experimental mice groups
Normal control group
OVX + Vehicle
Micro-computed tomography imaging and volumetric osteolysis analysis
Seven calvariae per group were dissected after sacrifice. Specimens were freed of all soft tissues, and fixed in 4% neutralized paraformaldehyde. The skulls were analyzed with a high-resolution micro-computed tomograph (micro-CT) (Skyscan 1172; Skyscan, Aartselaar, Belgium) to perform qualitative and quantitative analyses of calvarial bone. Imaging analysis mainly focused on the osseous properties in the area of the skull sagittal suture. The radiographic projections (n = 210) were acquired at 80 kV and 100 μA with an exposure time of 100 ms. Eight frames were averaged for each rotation increment of 0.9° to increase the signal to noise ratio. 3D images were reconstructed with a voxel average size of 10 μm, using the manufacturer reconstruction software (NRecon, Skyscan). Qualitative and quantitative data were analyzed with a global fixed threshold . To minimize the bias from the 3D orientation of the calvaria, a spheric volume of interest (VOI of 2 mm diameter) with the midline suture of the skull in its center was defined, as previously described . For quantitative analysis of PE particle-induced osteolysis, the resident software (CTAn, Skyscan) was used to obtain the following measurements within the VOI: bone volume (BV, mm3), and trabecular thickness (Tb.Th., mm). To address bone tissue mineralization following oestrogen depletion/substitution, a relative density measurement was computed. For this purpose, the mean value of grey-level intensity, reflecting the density of bone tissue, was obtained in entire calvariae.
Histologic evaluation of osteolysis
Calvariae were processed undecalcified after embedding in polymethyl-methacrylate according to a method previously described . Sections (10 μm) were obtained at the depth where the presence of particles was detected within the calvaria tissue. These sections were stained with Stevenel Blue and picrofuchsine and a serial section stained for tartrate-specific acid phosphatase-positive (TRAP) osteoclasts (Acid Phosphatase kit, Sigma-Aldrich, Steinheim, Germany). Using a magnification of 20×, the histomorphometric analysis of each calvaria cap was performed on the most central section and on four adjacent sections. The region of interest was defined as previously recommended . The sagittal suture area (SSA) was determined by tracing the area of soft tissue between the parietal bones. It included resorption pits on the superior surface of the calvaria visible in the same field as the midline suture. To determine bone thickness, sections were divided using a digital caliper in four 100 μm steps to the left and right sides of the midline suture respectively. The measurements were expressed as a percentage of the mean ratio of bone thickness to the total tissue thickness (BT/TT) of the nine regional measurements in the five adjacent sections. To quantify bone loss, results were also expressed as a percentage of the mean difference of BT/TT (Δ(BT/TT)) between sham-operated and particle-implanted animals, in normal controls, sham-OVX, OVX, and OVX + E mice groups. Osteoclasts were identified as large multinucleated cells located on the bone perimeter within a resorption lacuna. Their localization was confirmed in a serial section stained for tartrate-specific acid phosphatase. The osteoclast number was measured in the region of interest of the five consecutive calvaria sections.
Calvariae were removed en bloc under sterile conditions from five animals per group randomly assigned for culture. Each calvaria was placed into one well of 12 wells/plate and cultured with 1 ml serum-and phenol-free Dulbecco's modified Eagle's medium (DMEM) with glutamine (Invitrogen, Paisley, UK), and 1% penicillin and streptomycin at 37°C and 5% CO2 for 24 h. Twenty four hours later, the culture medium was collected and stored at -80°C for the assay of IL-1β, IL-6, TNF-α and RANKL secretion. Then, calvariae were calcinated and ashes weighted to normalize the production of cytokines.
ELISA for IL-1β, IL-6, TNF-α and RANKL detection
To measure IL-6 concentration in serum, blood was obtained by cardiac puncture before death, and collected in heparinized tubes. Blood samples were then centrifuged at 3,000 × g for 10 minutes, aliquoted and frozen at -80°C until assayed. Serum measurements of IL-6 were performed using quantitative, noncompetitive, sandwich enzyme-linked immunosorbent assay kit for detecting mouse IL-6 (Quantikine, R&D Systems Europe, Ltd, Abingdon, UK). Similarly, ELISA kits for detecting mouse IL-6, IL-1β, TNF-α and RANKL (R&D Systems) were employed to measure cytokines released into organ culture supernatant. The detection limits of the assay were 1.6 pg/mL for IL-6, 3 pg/mL for IL-1β, 5.1 pg/mL for TNF-α, and 5 pg/mL for RANKL. Cytokines levels lower than the detection limit were considered to be 0 pg/ml. Absorbance was read in an ELISA reader (Micro-Quant, Bio-Tek Instruments, Colmar, France) at 490 and 540 nm as per manufacturer's instructions.
Quantitative real-time polymerase chain reaction
Calvariae were removed from culture medium, and immediately snap-frozen in liquid nitrogen, and pulverized to powder in a stainless steel mortar. RNA was extracted with 1 mL Trizol® reagent (Invitrogen, Carlsbad, CA, USA), using the manufacturer's protocol. Quantity and purity of RNA was determined by absorbance on a NanoDrop™ 1000 Spectrophotometer (Labtech France, Palaiseau, France) at 260 and 280 nm. All samples had ratios >1.7 and were accepted for analysis.
Samples of total RNA were reverse-transcribed using the first-strand synthesis kit of SuperScript™ II Reverse Transcriptase (Invitrogen). Quantitative gene expression analyses were carried out using Real-time PCR by means of the TaqMan™ Gene Expression Assays Protocol (mouse RANK: Mm00437135_m1, mouse RANKL: Mm01313943_m1, mouse OPG: Mm01205928_m1, and human 18S rRNA: Hs99999901_s1; Applied Biosystems, Foster City, CA, USA) and the iCycler thermal cycler RT-PCR Detection System, coupled to MyiQ™ Single-Color software (Bio-Rad, Hercules, CA, USA). The absolute number of gene copies was normalized using 18s rRNA and the relative quantification of the genes was calculated using the "comparative C T (threshold cycle) method" as per manufacturer's instructions (Applied Biosystems).
All values are presented as means ± SEM. Quantitative parameters obtained from micro-CT (BV and Tb.Th) were analyzed by two-tailed Student's t-test within each group. Comparisons across unpaired groups were made according to the Mann-Whitney U test. Data concerning osteoclast number, sagittal suture area, and bone thickness were initially analyzed using a one-way analysis of variance (ANOVA). Post hoc comparison between groups used the Fisher's protected least significant difference. Two-way ANOVA was performed to determine whether there was a significant effect of either polyethylene particles or ovariectomy or oestrogen supplementation on osteoclast number, sagittal suture area and bone thickness. Cytokines concentrations and mRNAs expression were analyzed using one-way ANOVA followed by the Bonferroni/Dunnet's test. The level of statistical significance was set at P < 0.05.
Changes after OVX
All mice had increased body-weight by the end of the experiment. The final body-weight gain was +18% in the OVX group as compared to +6.8% (P < 0.0001), +3.5% (P < 0.0001), and +11% (P = 0.0001) in normal controls, sham-OVX mice, and OVX+E mice, respectively.
At sacrifice, atrophy of uterine tissue was noted, indicating the effectiveness of oestrogen privation following ovariectomy. There was a significant difference in uterine weight in OVX mice group (mean, 24.5 ± 3.6 mg), as compared to normal control animals (mean, 107.9 ± 12 mg, P < 0.0001), sham-OVX mice (mean, 86.4 ± 17 mg, P < 0.0001) and OVX+E mice (mean, 80.2 ± 10.9 mg, P < 0.0001). In contrast, uterine weight was notably less altered after oestrogen supplementation in OVX animals as compared to normal controls (80.2 ± 10.9 mg versus 107.9 ± 12 mg, P = 0.002).
Micro-CT evaluation of osteolysis
Histomorphometric results for each mice group
Normal control group
OVX + Vehicle
SSA (mm 2 )
0.036 ± 0.008
(0.008 to .076)
0.10 ± 0.04
(0.05 to 0.33)
0.034 ± 0.007
(0.008 to 0.07)
0.093 ± 0.03
(0.05 to 0.34)
0.026 ± 0.01
(0.006 to 0.1)
0.09 ± 0.04
(0.01 to 0.35)
0.038 ± 0.01
(0.01 to 0.11)
0.20 ± 0.05
(0.07 to 0.46)
60 ± 4.7%
(42% to 80%)
48 ± 5.3%
(23% to 73%)
62 ± 4.6%
(49% to 80%)
45 ± 4%
(23% to 56%)
55 ± 5.2%
(35% to 73%)
49 ± 4.9%
(26% to 65%)
54 ± 5.5%
(31% to 73%)
37 ± 5.1%
(17% to 55%)
-12 ± 5.3%
(-37% to 12%)
-16 ± 4.5%
(-39% to 5%)
-6.7 ± 4.9%
(-30% to 9%)
-17 ± 5%
(-37% to 1.2%)
0.31 ± 0.3
(0 to 2)
2.2 ± 0.7
(0 to 5)
0.42 ± 0.3
(0 to 2)
2.5 ± 0.7
(0 to 5)
0.65 ± 0.4
(0 to 3)
0.7 ± 0.5
(0 to 4)
0.27 ± 0.2
(0 to 1)
2.1 ± 0.8
(0 to 6)
One-way ANOVA showed a significant difference for bone thickness (P < 0.0001). Implantation of PE particles resulted in a marked decrease in BT/TT in normal control group (P = 0.001), in sham-OVX group (P < 0.001), and in OVX+E group (P < 0.0001). However, the presence of PE particles did not influence BT/TT in OVX group (P = 0.088). Also, two-way ANOVA showed an independent effect of ovariectomy on BT/TT (P < 0.001) in the absence of particles.
Serum levels of IL-6
Production of cytokines in organ culture
Quantitation of RANKL and OPG mRNA expressions in calvariae
In a recent work , we have shown that experimental stimulation of bone turnover by OVX resulted in a paradoxical decrease in particle-induced osteolysis in the murine calvaria model. To test the hypothesis that oestrogen-deficiency induced by OVX modulated the bone response to particulate debris, we supplemented PE particle-implanted OVX mice with 17β-estradiol. Then, we evaluated osteolysis and the involvement of the pro-inflammatory cytokines IL-6, IL-1β, TNF-α, and RANKL.
Our experiments show that the presence of PE particles induced an osteolytic reaction in bone calvaria in normal controls, in sham-OVX mice and in OVX+E mice, as illustrated by an extensive bone resorption and an intense inflammatory reaction involving both bone and periosteal tissue. In contrast, this process was considerably attenuated in OVX mice, with almost no modification in trabecular thickness, osteoclast number and periosteum thickness following PE implantation. In addition, Bone volume appeared consistently less altered following particles implantation, as compared to normal controls and OVX mice supplemented with oestrogen. Taken together, these data suggest that oestrogen deficiency influenced positively bone response to particulate debris. This finding appears paradoxical as clinical trials [14–16] and experimental studies [17, 18] have demonstrated the protective effects of oestrogen against inflammatory processes, such as rheumatoid arthritis (RA). However, the relationship between oestrogen and inflammation is controversial and might be related to a different response of bone and inflammation cells. Although it is admitted that oestrogen provides a protection against inflammation, it is also known that female patients are more prone to develop inflammatory diseases such as RA . This point illustrates the dual action of oestrogen, both anti- and pro-inflammatory.
Numerous cellular and molecular mechanisms leading to bone resorption are common to osteolysis and oestrogen deficiency pathways. Cytokines such as IL-1, IL6, TNF-α, and RANKL are up-regulated in both bone-resorptive situations [20–24]. Differentiation of RANKL-primed osteoclasts precursors, activation of mature osteoclasts, and osteoclasts survival are enhanced by TNF-α . Zhang et al.  showed that TNF-α and RANKL act synergistically on osteoclastogenesis in vitro. The role of TNF-α in OVX-induced bone loss is well documented [20, 27, 28]. Collectively, these studies suggest that up-regulation of TNF-producing cells in the bone marrow is a mechanism by which oestrogen deficiency induces bone loss. Indeed, functional blockade of TNF-α in mice leads to protection from OVX-induced bone loss . Accordingly, we found that TNF-α local production was consistently altered in oestrogen deficient mice, suggesting its involvement in limited osteoclastogenesis in this group.
In our experiments, local release of pro-inflammatory cytokines IL1- β and IL-6 appeared heterogeneous. On one hand, we found that pro-inflammatory cytokine IL-1 β was stimulated by PE particles in all groups. On the other hand, IL-6 local rates were not increased in the presence of PE particles in any group. Indeed, it has been suggested that the involvement of pro cytokines in vivo may be difficult to demonstrate due to compensatory process , and to the delayed time course of release after particle implantation. Conversely, serum IL-6 was stimulated by PE implantation in normal controls, sham-OVX and E-supplemented OVX mice, whereas no significant change occurred in OVX mice. This point correlated well with the degree of osteolytic reaction combining bone resorption and periosteal inflammatory granuloma. The role of IL-6 as a stimulator of bone resorption in post-menopausal osteoporosis is well-known . IL-6 promotes bone resorption by affecting osteoclast differentiation and activity . Our results are in line with clinical data showing that serum levels of IL-6 were consistently increased in patients with loosened hip prosthesis . However, authors failed to correlate serum levels of IL-6 and the volume of osteolysis . These discrepancies suggest that serum cytokine levels may be influenced by various factors, such as cytokine release from other organs, and cytokine clearance rates from the joint. Taken together with our findings, we speculate that serum and local IL-6 changes may be involved in the mechanism underlying the reduction of particle-induced osteolysis observed in OVX mice. Thus, the hormonal status appears as a key factor influencing serum IL-6 levels to be considered in further clinical studies.
We observed that the combination of two bone-resorptive stimuli resulted in a down-regulation of local pro-resorptive cytokines TNF-α and RANKL, in parallel with a limitation of bone loss. The latter appeared as a consequence of decreased osteoclast activity and/or recruitment and/or accelerated apoptosis. We assume this process is regulated by the RANK/RANKL/OPG pathway, synergistically with TNF-α secretion, since RANKL is required for osteoclasts differentiation, survival and activity . Pro-resorptive cytokine production could have been altered at the cellular level. Hence, particle-induced osteolysis and postmenopausal osteoporosis represent pro-inflammatory states with increased inflammatory cytokines and activated T cells . Cytokines produced or regulated by T cells can enhance osteoclast formation by increasing the RANKL/OPG ratio . Oestrogen deficiency also increases the RANKL/OPG ratio through increases in pro-inflammatory effectors, including IL-1β, IL-6, IL-11, TNF-α, M-CSF and PGE . RANKL expression was observed in osteoblasts/stromal cells and bone marrow in postmenopausal women. The molecular basis of the mechanism by which oestrogen deficiency induces accelerated osteoclastogenesis is not yet elucidated . In mice, the selective ablation of oestrogen receptor in mature osteoclasts mimicked an osteoporotic bone phenotype , suggesting that oestrogen directly regulates the life span of differentiated osteoclasts, independently of an inflammatory pathway.
We hypothesize that the paradoxical decrease in bone response to PE particles in OVX mice could be driven by an innate protective mechanism that ultimately attenuated focal bone resorption. Hence, a tight control of innate immunity is essential because a disproportionate immune response may considerably compound morbidity. Recent studies suggested the involvement of T cells not only in pathogen clearance but also in regulating adaptative and innate immunity . Recently, Guarda et al.  reported that excessive inflammation was suppressed by effector and memory T cells, via the blockade of mature IL-1β secretion, suggesting a possible mechanism for the control of excessive inflammatory responses.
We recognize limitations may have affected our findings. First, calvarial bone tissue considerably differs from long bone tissue with respect to cells, matrix composition and mineralization. Osteoclasts activity has been shown to be highly variable, depending on bone-site origin [40, 41]. Specifically, it was reported that proteolytic enzymes used for bone matrix digestion [40, 42], expression of TRAP enzyme, and size of osteoclasts originated from calvarial bone differed from those present in long bones [41, 43]. Additionally, van den Bos et al.  reported that calvarial bone exhibited differences in matrix composition compared to long bone, including degree of mineralization, amounts of collagen, osteoglycin, and pigment epithelium derived factor. These data together indicate a putative difference in bone resorption characteristics in calvaria. Although the murine calvarial model has been extensively used to evaluate particle-induced osteolysis [4–6], the clinical relevance of our data should be considered with caution. Second, the osteolysis murine model does not fully reproduce the loading conditions of a prosthetic implant subjected to loosening. The consequences of OVX on mouse calvarial bone have been poorly studied. However, our observations revealed that basal calvarial bone thickness was significantly reduced in OVX mice, confirming previous findings [10, 45]. This is consistent with bone resorption of the skull and subsequent parietal bone thinning observed in postmenopausal osteoporotic women . Therefore, the current experimental protocol likely mimicked comparable cellular and biologic bone responses in OVX mice that occur in the early postmenopausal period. In the present work, we did not evaluate cytokines local rates in a time-dependant fashion after particles implantation. Hence, pro-inflammatory cytokines are known to be highly labile and, subsequently, their local and serum concentrations may vary with time. However, we limited our experiments to the time period preceding the onset of theoretical substantial bone repair. Therefore, it is likely that our cytokines and mRNA evaluations are compatible with bone cellular response tested in our model.
The present study analysed the consequences of oestrogen deprivation in a murine model of particle-induced osteolysis. We demonstrated that oestrogen deficiency significantly attenuated osteolytic response to PE particles. This phenomenon was associated with a down-regulation of pro-inflammatory and pro-resorptive cytokines TNF-α and RANKL, together with an absence of increase of serum IL-6. We favour the alternative that the combination of two bone-resorptive phenomenon altered cytokines production, possibly via the implication of the periosteum in this mice model.
enzyme-linked immunosorbent assay
Limulus Amebocyte Lysate
receptor activator of the nuclear factor κB
real-time polymerase chain reaction
sagittal suture area
tumor necrosis factor-α
tartrate-specific acid phosphatase-positive
volume of interest.
The authors would like to thank Isabel Le Disquet, IFR de Biologie Intégrative, Service de Microscopie Electronique, Université Pierre et Marie Curie-Paris VI, for providing particles scanning electron microscopy analysis, and Laurent Havard, Service de Pharmacie, European Teaching Hospital, Paris, for providing particles decontamination and endotoxins tests.
- Willert HG, Bertram H, Buchhorn GH: Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res. 1990, 258: 95-107.Google Scholar
- Schwarz EM, O'Keefe RJ, Looney RJ: Bone implant interface, osteolysis and potential therapies. J Musculoskelet Neuronal Interact. 2004, 4: 390-392.Google Scholar
- Kobayashi S, Takaoka K, Saito N, Hisa K: Factors affecting aseptic failure of fixation after primary Charnley total hip arthroplasty. Multivariate survival analysis. J Bone Joint Surg Am. 1997, 79: 1618-1627.Google Scholar
- von Knoch M, Jewison DE, Sibonga JD, Turner RT, Morrey BF, Loer F, Berry DJ, Scully SP: Decrease in particle-induced osteolysis in obese (ob/ob) mice. Biomaterials. 2004, 25: 4675-4681. 10.1016/j.biomaterials.2004.02.069.View ArticleGoogle Scholar
- Zhang C, Tang T, Ren W, Zhang X, Dai K: Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res. 2008, 57: 211-215. 10.1007/s00011-007-7040-3.View ArticleGoogle Scholar
- Nich C, Marchadier A, Sedel L, Petite H, Vidal C, Hamadouche M: Decrease in particle-induced osteolysis in ovariectomized mice. J Orthop Res. 2010, 28: 178-183.Google Scholar
- Ishiguro N, Kojima T, Ito T, Saga S, Anma H, Kurokouchi K, Iwahori Y, Iwase T, Iwata H: Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res. 1997, 35: 399-406. 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A.View ArticleGoogle Scholar
- Green TR, Fisher J, Matthews JB, Stone MH, Ingham E: Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res. 2000, 53: 490-497. 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7.View ArticleGoogle Scholar
- Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y: IL-6, RANKL, TNFalpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004, 15: 49-60. 10.1016/j.cytogfr.2003.10.005.View ArticleGoogle Scholar
- Wronski TJ, Dann LM, Scott KS, Cintrón M: Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int. 1989, 45: 360-366. 10.1007/BF02556007.View ArticleGoogle Scholar
- Passeri G, Girasole G, Jilka RL, Manolagas SC: Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology. 1993, 133: 822-828. 10.1210/en.133.2.822.Google Scholar
- Spelsberg TC, Subramaniam M, Riggs BL, Khosla S: The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol. 1999, 13: 819-828. 10.1210/me.13.6.819.View ArticleGoogle Scholar
- Müller R, van Campenhout H, van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, Rüegsegger P: Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone. 1998, 23: 59-66. 10.1016/S8756-3282(98)00068-4.View ArticleGoogle Scholar
- van den Brink HR, van Everdingen AA, van Wijk MJ, Jacobs JW, Bijlsma JW: Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis. 1993, 52: 862-865. 10.1136/ard.52.12.862.View ArticleGoogle Scholar
- Hall GM, Daniels M, Huskisson EC, Spector TD: A randomized controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis. 1994, 53: 112-116. 10.1136/ard.53.2.112.View ArticleGoogle Scholar
- D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H: Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis Res Ther. 2003, 5: 202-209. 10.1186/ar788.View ArticleGoogle Scholar
- Yoneda T, Ishimaru N, Arakaki R, Kobayashi M, Izawa T, Moriyama K, Hayashi Y: Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Endocrinology. 2004, 145: 2384-2391. 10.1210/en.2003-1536.View ArticleGoogle Scholar
- Subramanian S, Tovey M, Afentoulis M, Krogstad A, Vandenbark AA, Offner H: Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol. 2005, 115: 162-172. 10.1016/j.clim.2005.01.006.View ArticleGoogle Scholar
- da Silva JA, Willoughby DA: The influence of sex in arthritis: is cartilage an overlooked factor?. J Rheumatol. 1994, 21: 791-796.Google Scholar
- Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R: Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem. 1996, 271: 28890-28897. 10.1074/jbc.271.46.28890.View ArticleGoogle Scholar
- Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, Mc Cabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402: 304-309. 10.1038/46303.View ArticleGoogle Scholar
- Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, Mc Cabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA. 2000, 97: 1566-1571. 10.1073/pnas.97.4.1566.View ArticleGoogle Scholar
- Teitelbaum SL: Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab. 2000, 18: 344-349. 10.1007/s007740070007.View ArticleGoogle Scholar
- Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S: Estrogen prevents bone loss via oestrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007, 130: 811-823. 10.1016/j.cell.2007.07.025.View ArticleGoogle Scholar
- Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM: Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res. 2001, 16: 338-347. 10.1359/jbmr.2001.16.2.338.View ArticleGoogle Scholar
- Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y: Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem. 2001, 276: 563-568.View ArticleGoogle Scholar
- Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R: Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 1995, 136: 3054-3061. 10.1210/en.136.7.3054.Google Scholar
- Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R: Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which oestrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA. 2001, 98: 13960-13965. 10.1073/pnas.251534698.View ArticleGoogle Scholar
- Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM: Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone. 2007, 40: 1276-1283. 10.1016/j.bone.2006.12.053.View ArticleGoogle Scholar
- Lerner UH: Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res. 2006, 85: 596-607. 10.1177/154405910608500704.View ArticleGoogle Scholar
- Lorenzo J: Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest. 2000, 106: 749-752. 10.1172/JCI11089.View ArticleGoogle Scholar
- Hernigou P, Intrator L, Bahrami T, Bensussan A, Farcet JP: Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res. 1999, 366: 147-154.View ArticleGoogle Scholar
- Tanaka R, Yasunaga Y, Hisatome T, Yamasaki T, Iwamori H, Ochi M: Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty. 2005, 20: 1049-1054. 10.1016/j.arth.2005.03.034.View ArticleGoogle Scholar
- Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R: Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000, 106: 1229-1237. 10.1172/JCI11066.View ArticleGoogle Scholar
- Weitzmann MN, Pacifici R: The role of T lymphocytes in bone metabolism. Immunol Rev. 2005, 208: 154-168. 10.1111/j.0105-2896.2005.00324.x.View ArticleGoogle Scholar
- Pacifici R: Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996, 11: 1043-1051.View ArticleGoogle Scholar
- Sato T, Watanabe K, Masuhara M, Hada N, Hakeda Y: Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. J Bone Miner Metab. 2007, 25: 19-27.View ArticleGoogle Scholar
- Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, Fu YX: Adaptive immune cells temper initial innate responses. Nat Med. 2007, 13: 1248-1252. 10.1038/nm1633.View ArticleGoogle Scholar
- Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J: T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature. 2009, 460: 269-273. 10.1038/nature08100.View ArticleGoogle Scholar
- Everts V, de Vries TJ, Helfrich MH: Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta. 2009, 1792: 757-765.View ArticleGoogle Scholar
- de Souza Faloni AP, Schoenmaker T, Azari A, Katchburian E, Cerri PS, de Vries TJ, Everts V: Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int. 2011, 88: 63-74. 10.1007/s00223-010-9418-4.View ArticleGoogle Scholar
- Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res. 2006, 21: 1399-1408. 10.1359/jbmr.060614.View ArticleGoogle Scholar
- Perez-Amodio S, Jansen DC, Schoenmaker T, Vogels IM, Reinheckel T, Hayman AR, Cox TM, Saftig P, Beertsen W, Everts V: Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcif Tissue Int. 2006, 79: 245-254. 10.1007/s00223-005-0289-z.View ArticleGoogle Scholar
- van de Bos T, Speijer D, Bank RA, Bromme D, Everts V: Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: Special emphasis on collagen. Bone. 2008, 43: 459-468. 10.1016/j.bone.2008.05.009.View ArticleGoogle Scholar
- Libouban H, Moreau MF, Baslé MF, Bataille R, Chappard D: Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone. 2003, 33: 283-292. 10.1016/S8756-3282(03)00196-0.View ArticleGoogle Scholar
- Takata S, Takao S, Yoshida S, Hayashi F, Yasui N: Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with pariétal thinning of skull. J Med Invest. 2008, 55: 297-302. 10.2152/jmi.55.297.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.